A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicineJohanne U. Hermansen, Sigrid S. Skånland|Cell Death Discovery|2023Cited by 17
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Martina Seiffert, Haniyeh Yazdanparast et al.|Nature Communications|2025Cited by 5